Disinvestment in cancer care: a survey investigating European countries' opinions and views

Maria Lucia Specchia, Giuseppe La Torre, Giovanna Elisa Calabrò, Paolo Villari, Roberto Grilli, Antonio Federici, Walter Ricciardi, Chiara de Waure

Research output: Contribution to journalArticle

Abstract

Background: The current economic context calls for rationalizing health resources that can be pursued through disinvestment from low value health technologies to invest in the best performing ones, ensuring high healthcare quality. Oncology is a field where, because of high costs of health technologies and rapid innovation, disinvestment is crucial.

Methods: On this basis, the research team investigated through a survey, based on a questionnaire, opinions and views of representatives of European countries about disinvestment, in terms of fields of application, potential advocates and barriers, specifically focusing on cancer care.

Results: A total of 17 questionnaires were filled in (response rate: 32.1%). The survey showed disinvestment is applied in several countries as a tool for containing health care expenditures and identifying obsolete technologies/ineffective interventions. Clinicians' resistance to change and industries' opposition are recognized as the most important barriers to the implementation of disinvestment policies. Potential targets of disinvestment in cancer are seen in diagnostic and therapeutic areas.

Conclusion: Despite the agreement on fields of waste and of disinvestment policies, operational methods to put disinvestment in place are lacking. Since they should rely on an inclusive assessment of the technology, Health Technology Assessment may represent a good approach.

Original languageEnglish
Pages (from-to)987-992
Number of pages6
JournalEuropean Journal of Public Health
Volume28
Issue number6
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Biomedical Technology Assessment
Biomedical Technology
High-Cost Technology
Neoplasms
Quality of Health Care
Health Resources
Health Expenditures
Industry
Economics
Technology
Delivery of Health Care
Surveys and Questionnaires
Research
Therapeutics

Cite this

Specchia, M. L., La Torre, G., Calabrò, G. E., Villari, P., Grilli, R., Federici, A., ... de Waure, C. (2018). Disinvestment in cancer care: a survey investigating European countries' opinions and views. European Journal of Public Health, 28(6), 987-992. https://doi.org/10.1093/eurpub/cky033

Disinvestment in cancer care : a survey investigating European countries' opinions and views. / Specchia, Maria Lucia; La Torre, Giuseppe; Calabrò, Giovanna Elisa; Villari, Paolo; Grilli, Roberto; Federici, Antonio; Ricciardi, Walter; de Waure, Chiara.

In: European Journal of Public Health, Vol. 28, No. 6, 01.12.2018, p. 987-992.

Research output: Contribution to journalArticle

Specchia, ML, La Torre, G, Calabrò, GE, Villari, P, Grilli, R, Federici, A, Ricciardi, W & de Waure, C 2018, 'Disinvestment in cancer care: a survey investigating European countries' opinions and views', European Journal of Public Health, vol. 28, no. 6, pp. 987-992. https://doi.org/10.1093/eurpub/cky033
Specchia, Maria Lucia ; La Torre, Giuseppe ; Calabrò, Giovanna Elisa ; Villari, Paolo ; Grilli, Roberto ; Federici, Antonio ; Ricciardi, Walter ; de Waure, Chiara. / Disinvestment in cancer care : a survey investigating European countries' opinions and views. In: European Journal of Public Health. 2018 ; Vol. 28, No. 6. pp. 987-992.
@article{43c5b1672f9b41cf8d93519aecf626d2,
title = "Disinvestment in cancer care: a survey investigating European countries' opinions and views",
abstract = "Background: The current economic context calls for rationalizing health resources that can be pursued through disinvestment from low value health technologies to invest in the best performing ones, ensuring high healthcare quality. Oncology is a field where, because of high costs of health technologies and rapid innovation, disinvestment is crucial.Methods: On this basis, the research team investigated through a survey, based on a questionnaire, opinions and views of representatives of European countries about disinvestment, in terms of fields of application, potential advocates and barriers, specifically focusing on cancer care.Results: A total of 17 questionnaires were filled in (response rate: 32.1{\%}). The survey showed disinvestment is applied in several countries as a tool for containing health care expenditures and identifying obsolete technologies/ineffective interventions. Clinicians' resistance to change and industries' opposition are recognized as the most important barriers to the implementation of disinvestment policies. Potential targets of disinvestment in cancer are seen in diagnostic and therapeutic areas.Conclusion: Despite the agreement on fields of waste and of disinvestment policies, operational methods to put disinvestment in place are lacking. Since they should rely on an inclusive assessment of the technology, Health Technology Assessment may represent a good approach.",
author = "Specchia, {Maria Lucia} and {La Torre}, Giuseppe and Calabr{\`o}, {Giovanna Elisa} and Paolo Villari and Roberto Grilli and Antonio Federici and Walter Ricciardi and {de Waure}, Chiara",
year = "2018",
month = "12",
day = "1",
doi = "10.1093/eurpub/cky033",
language = "English",
volume = "28",
pages = "987--992",
journal = "European Journal of Public Health",
issn = "1101-1262",
publisher = "NLM (Medline)",
number = "6",

}

TY - JOUR

T1 - Disinvestment in cancer care

T2 - a survey investigating European countries' opinions and views

AU - Specchia, Maria Lucia

AU - La Torre, Giuseppe

AU - Calabrò, Giovanna Elisa

AU - Villari, Paolo

AU - Grilli, Roberto

AU - Federici, Antonio

AU - Ricciardi, Walter

AU - de Waure, Chiara

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: The current economic context calls for rationalizing health resources that can be pursued through disinvestment from low value health technologies to invest in the best performing ones, ensuring high healthcare quality. Oncology is a field where, because of high costs of health technologies and rapid innovation, disinvestment is crucial.Methods: On this basis, the research team investigated through a survey, based on a questionnaire, opinions and views of representatives of European countries about disinvestment, in terms of fields of application, potential advocates and barriers, specifically focusing on cancer care.Results: A total of 17 questionnaires were filled in (response rate: 32.1%). The survey showed disinvestment is applied in several countries as a tool for containing health care expenditures and identifying obsolete technologies/ineffective interventions. Clinicians' resistance to change and industries' opposition are recognized as the most important barriers to the implementation of disinvestment policies. Potential targets of disinvestment in cancer are seen in diagnostic and therapeutic areas.Conclusion: Despite the agreement on fields of waste and of disinvestment policies, operational methods to put disinvestment in place are lacking. Since they should rely on an inclusive assessment of the technology, Health Technology Assessment may represent a good approach.

AB - Background: The current economic context calls for rationalizing health resources that can be pursued through disinvestment from low value health technologies to invest in the best performing ones, ensuring high healthcare quality. Oncology is a field where, because of high costs of health technologies and rapid innovation, disinvestment is crucial.Methods: On this basis, the research team investigated through a survey, based on a questionnaire, opinions and views of representatives of European countries about disinvestment, in terms of fields of application, potential advocates and barriers, specifically focusing on cancer care.Results: A total of 17 questionnaires were filled in (response rate: 32.1%). The survey showed disinvestment is applied in several countries as a tool for containing health care expenditures and identifying obsolete technologies/ineffective interventions. Clinicians' resistance to change and industries' opposition are recognized as the most important barriers to the implementation of disinvestment policies. Potential targets of disinvestment in cancer are seen in diagnostic and therapeutic areas.Conclusion: Despite the agreement on fields of waste and of disinvestment policies, operational methods to put disinvestment in place are lacking. Since they should rely on an inclusive assessment of the technology, Health Technology Assessment may represent a good approach.

U2 - 10.1093/eurpub/cky033

DO - 10.1093/eurpub/cky033

M3 - Article

C2 - 29538676

VL - 28

SP - 987

EP - 992

JO - European Journal of Public Health

JF - European Journal of Public Health

SN - 1101-1262

IS - 6

ER -